Influvac Tetra 2023/2024 Vaccine helps protect you from influenza (flu). Influvac Tetra Vaccine is made from inactivated (dead) influenza virus. Influvac Tetra 2023/2024 Vaccine is given as an injection and is typically administered to adults and children over 6 months of age. The Influvac Tetra 2023/2024 Injection is designed to protect against the three most common strains of influenza (influenza A and B) that are expected to circulate in a given year. Influvac Tetra Vaccine works by stimulating the immune system to produce antibodies against the influenza virus, which can then provide protection against the virus if a person is exposed to it. The Influvac Tetra 2023/2024 Injection is considered to be safe and is typically administered annually to help protect against seasonal influenza.
Getting the Influvac Tetra may cause mild side effects, however,Influvac Tetra Vaccine is safer to be vaccinated than to contract influenza. The flu can result in thousands of deaths annually. Common side effects of the Influvac Tetra 2023/2024 include headaches, fatigue, weakness, and pain/swelling at the injection site. These symptoms typically do not last long. If you have any concerns about the side effects, it is best to consult with your doctor.
It is important to inform your doctor of any current illnesses or fever, and any past allergic reactions to vaccines before receiving the Influvac Tetra Vaccine. Additionally, it is essential to discuss any current medications you may be taking as they may interact with the Influvac Tetra 2023/2024 Vaccine. Though it may not provide full protection, the Influvac Tetra 2023/2024 Injection can still reduce symptoms if you do contract the flu. However, it will not protect against avian flu or the common cold. If you are pregnant or breastfeeding, it is recommended to consult with your doctor before getting the Influvac Tetra 2023/2024.
Prevention of Influenza (flu): Influvac Tetra 2023/2024 Vaccine is used to prevent Influenza, also known as the flu, is a contagious respiratory illness caused by influenza viruses. Symptoms include fever, cough, sore throat, runny or stuffy nose, muscle or body aches, fatigue, and sometimes vomiting and diarrhoea. The flu can range in severity from mild to severe, and can lead to complications such as pneumonia, bronchitis, and sinus and ear infections.
Influvac Tetra Vaccine helps protect against the most common strains of the flu virus, reducing the risk of contracting the flu.
The Influvac Tetra 2023/2024 Vaccine is particularly important for vulnerable populations, such as young children, the elderly, and people with certain medical conditions, as they are at a higher risk of complications from the flu.
Influvac Tetra 2023/2024 can help prevent hospitalizations and deaths related to the flu.
When more people are vaccinated, the spread of the flu in a community is reduced, which helps protect people who are unable to get vaccinated, such as infants and people with certain medical conditions.
Influvac Tetra 2023/2024 is an inexpensive way to prevent flu and its complications, it is also considered cost-effective as it saves on the cost of treating flu-related complications, absenteeism, and lost productivity.
Influvac Tetra 2023/2024 Vaccine also known as "killed" influenza vaccines, are made from inactivated (killed) forms of the influenza virus. Influvac Tetra 2023/2024 injected into the body and stimulate an immune response, which includes the production of antibodies that protect against the specific strains of influenza included in the vaccine. The Influvac Tetra Vaccine does not cause the flu, as the virus is dead and cannot infect the person receiving the vaccine. Influvac Tetra Vaccine typically takes about two weeks for the body to develop immunity after receiving the Influvac Tetra 2023/2024 Injection.
It is generally not recommended to drink alcohol while taking Influvac Tetra Vaccine. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
It is uncertain if the Influvac Tetra 2023/2024 Injection affects one's ability to drive. If any symptoms that impair focus and reaction occur, do not operate a vehicle.
It is recommended to consult with a doctor as there is limited information on the effects of Influvac Tetra 2023/2024 in patients with kidney disease.
It is recommended to consult with a doctor as there is limited information on the effects of Influvac Tetra in patients with liver disease.
It is generally considered safe for a breastfeeding mother to receive an Influvac Tetra Vaccine. The antibodies produced in response to the vaccine can be passed on to the baby through breast milk, which can provide some protection against influenza for the baby. However, as with any medication or vaccine, it is always best to consult with your healthcare provider to determine the best course of action for you and your baby.
Influvac Tetra Vaccine is safe for use during pregnancy. The Centers for Disease Control and Prevention (CDC) recommends that all pregnant women receive the Influvac Tetra 2023/2024 during any trimester of their pregnancy. This is because pregnant women are at increased risk for serious complications from influenza, such as hospitalization and death.
1. INFLUVAC Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated), Abbott Laboratories Ltd., Product Leaflet
2. FLUARIX QUADRIVALENT (Influenza Vaccine) injectable suspension, for intramuscular use, [Revised: 07/2022], GlaxoSmithKline Biologicals, Dresden, Germany, Product Leaflet
3. Influvac Tetra, suspension for injection in a pre-filled syringe Influenza vaccine (surface antigen, inactivated) 2022/2023 season, Abbott Biologicals B.V. Product Leaflet
4. INFLUVAC TETRA Quadrivalent influenza vaccine, surface antigen, inactivated Suspension for Injection, each 0.5 mL pre-filled syringe contains neuraminidase and 15 mcg haemagglutinin of each virus strain as recommended by the WHO and NACI, intramuscular injection or deep subcutaneous injection, BGP Products B.V., licensed use by BGP Pharma ULC, Etobicoke, Ontario, [Date of Revision:MAY 13, 2022], Product Monograph